GlassScriptPhysician profile
Tigran Khachatryan
NPI 1982108981
$959.59
in general payments reported to CMS, 2019-2025
6 companies · $302 in 2025
The $302 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $221 · 2024: $436 · 2025: $302.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $911 · Travel and Lodging: $48.12.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $911.47 |
| Travel and Lodging | $48.12 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Microvention, INC. | $393.77 | 2023-2025 | Stent, Tubing Kit - Stroke, Web Aneurysm Embolization System |
| Qapel Medical INC | $212.85 | 2024 | |
| Silk Road Medical, INC. | $159.49 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Medical Device Business Services, INC. | $124.65 | 2025 | |
| Abiomed | $48.12 | 2023 | Impella |
| Esperion Therapeutics, INC. | $20.71 | 2023 | Nexletol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tigran Khachatryan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.